| __timestamp | Catalyst Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 55962693 |
| Thursday, January 1, 2015 | 11801342 | 78655788 |
| Friday, January 1, 2016 | 11369941 | 95723069 |
| Sunday, January 1, 2017 | 11375237 | 116808575 |
| Monday, January 1, 2018 | 19919204 | 106397017 |
| Tuesday, January 1, 2019 | 18842752 | 108431600 |
| Wednesday, January 1, 2020 | 16496715 | 141426832 |
| Friday, January 1, 2021 | 16936000 | 225200000 |
| Saturday, January 1, 2022 | 19789000 | 297812160 |
| Sunday, January 1, 2023 | 93150000 | 283614139 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, MorphoSys AG and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, MorphoSys AG consistently outspent Catalyst Pharmaceuticals, with R&D expenses peaking at approximately €298 million in 2022, a staggering 400% increase from 2014. In contrast, Catalyst Pharmaceuticals showed a more modest growth, with R&D spending reaching around €93 million in 2023, marking a significant leap from its 2014 figures. This disparity highlights MorphoSys AG's aggressive pursuit of innovation, while Catalyst Pharmaceuticals adopts a more conservative approach. As the pharmaceutical landscape continues to shift, these spending patterns may influence each company's ability to bring groundbreaking therapies to market.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE